Dietary fiber intake associates with improved survival and microbiomecomposition in allogeneic hematopoietic cell transplantation
Paredes, J.; Funnell, T.; Adintori, P.; Dai, A.; Smith, N.; Faustino Ramos, R. J.; Kaur, P.; Li, Z.; Pathak, K.; Funes, J.; Victor, K.; Ghale, R.; Doung, N.; Haber, J. M.; Sadeghi, K.; Pohl, C.; Huang, A.; Amoretti, L. A.; Molina, A.; Baichoo, M.; Elias, H.; Miltiadous, O.; Kousa, A. I.; Lemarquis, A. L.; James, S.; Catarina Gradissimo de Oliveira, A.; Shah, U. A.; Pirrotte, P.; Cross, J.; Peled, J. U.; Burgos da Silva, M.; Fei, T.; van den Brink, M. R.
Show abstract
Diet is linked to changes in gut microbiota and metabolite production with clinical relevance in several disease settings, although these effects remain poorly defined. We performed prospective, real-time diet monitoring (37,929 food items, 3,837 patient days) and longitudinal microbiome and metabolite profiling (1,230 fecal samples) in a clinical cohort of 173 patients undergoing allogeneic hematopoietic cell transplantation. Patients with pre-transplant fiber intake above the cohort average had significantly improved overall survival (p=0.014) and reduced incidence of grades 2-4 acute graft-versus-host disease (GVHD) (p=0.032) post-transplant. Those consuming insoluble fiber had increased microbial diversity, enriched butyrate-producing taxa, and depleted Enterococcus. Those who developed lower gastrointestinal GVHD had reduced fecal butyrate levels. In a GVHD preclinical model, we confirmed that a fiber-enriched diet increased survival, cecal butyrate, and regulatory-to-conventional T cell ratio. Thus, we demonstrated that dietary fiber has clinical significance as a modifiable factor with microbiome-mediated effects.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.